[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Human Rabies Immunoglobulin (IM) Market Analysis 2016-2020 and Forecast 2021-2026

March 2021 | 88 pages | ID: G4893E00CBA2EN
99Strategy

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SNAPSHOT

Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.
The global Human Rabies Immunoglobulin (IM) market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Human Rabies Immunoglobulin (IM) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • ERIG
  • HRIG
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
  • CSL Behring
  • Grifols
  • Sanofi
  • Sichuan Yuanda Shuyang
  • CNBG
  • Kamada
  • CBPO
  • Shuanglin Bio
  • Weiguang Bio
  • Shanghai RAAS
  • Bharat Serum
  • VINS
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
  • Category II Exposure
  • Category III Exposure
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc.)
  • South America (Brazil, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, South Africa etc.)
1 INDUSTRY OVERVIEW

1.1 Human Rabies Immunoglobulin (IM) Industry
Figure Human Rabies Immunoglobulin (IM) Industry Chain Structure
  1.1.1 Overview
  1.1.2 Development of Human Rabies Immunoglobulin (IM)
1.2 Market Segment
  1.2.1 Upstream
Table Upstream Segment of Human Rabies Immunoglobulin (IM)
  1.2.2 Downstream
Table Application Segment of Human Rabies Immunoglobulin (IM)
Table Global Human Rabies Immunoglobulin (IM) Market 2016-2026, by Application, in USD Million
  1.2.3 COVID-19 Impact
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 HUMAN RABIES IMMUNOGLOBULIN (IM) MARKET BY TYPE

3.1 By Type
  3.1.1 ERIG
Table Major Company List of ERIG
  3.1.2 HRIG
Table Major Company List of HRIG
3.2 Market Size
Table Global Human Rabies Immunoglobulin (IM) Market 2016-2020, by Type, in USD Million
Figure Global Human Rabies Immunoglobulin (IM) Market Growth 2016-2020, by Type, in USD Million
Table Global Human Rabies Immunoglobulin (IM) Market 2016-2020, by Type, in Volume
Figure Global Human Rabies Immunoglobulin (IM) Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Human Rabies Immunoglobulin (IM) Market Forecast 2021-2026, by Type, in USD Million
Table Global Human Rabies Immunoglobulin (IM) Market Forecast 2021-2026, by Type, in Volume

4 MAJOR COMPANIES LIST

4.1 CSL Behring (Company Profile, Sales Data etc.)
  4.1.1 CSL Behring Profile
Table CSL Behring Overview List
  4.1.2 CSL Behring Products & Services
  4.1.3 CSL Behring Business Operation Conditions
Table Business Operation of CSL Behring (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Grifols (Company Profile, Sales Data etc.)
  4.2.1 Grifols Profile
Table Grifols Overview List
  4.2.2 Grifols Products & Services
  4.2.3 Grifols Business Operation Conditions
Table Business Operation of Grifols (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Sanofi (Company Profile, Sales Data etc.)
  4.3.1 Sanofi Profile
Table Sanofi Overview List
  4.3.2 Sanofi Products & Services
  4.3.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Sichuan Yuanda Shuyang (Company Profile, Sales Data etc.)
  4.4.1 Sichuan Yuanda Shuyang Profile
Table Sichuan Yuanda Shuyang Overview List
  4.4.2 Sichuan Yuanda Shuyang Products & Services
  4.4.3 Sichuan Yuanda Shuyang Business Operation Conditions
Table Business Operation of Sichuan Yuanda Shuyang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 CNBG (Company Profile, Sales Data etc.)
  4.5.1 CNBG Profile
Table CNBG Overview List
  4.5.2 CNBG Products & Services
  4.5.3 CNBG Business Operation Conditions
Table Business Operation of CNBG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Kamada (Company Profile, Sales Data etc.)
  4.6.1 Kamada Profile
Table Kamada Overview List
  4.6.2 Kamada Products & Services
  4.6.3 Kamada Business Operation Conditions
Table Business Operation of Kamada (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 CBPO (Company Profile, Sales Data etc.)
  4.7.1 CBPO Profile
Table CBPO Overview List
  4.7.2 CBPO Products & Services
  4.7.3 CBPO Business Operation Conditions
Table Business Operation of CBPO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Shuanglin Bio (Company Profile, Sales Data etc.)
  4.8.1 Shuanglin Bio Profile
Table Shuanglin Bio Overview List
  4.8.2 Shuanglin Bio Products & Services
  4.8.3 Shuanglin Bio Business Operation Conditions
Table Business Operation of Shuanglin Bio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Weiguang Bio (Company Profile, Sales Data etc.)
  4.9.1 Weiguang Bio Profile
Table Weiguang Bio Overview List
  4.9.2 Weiguang Bio Products & Services
  4.9.3 Weiguang Bio Business Operation Conditions
Table Business Operation of Weiguang Bio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Shanghai RAAS (Company Profile, Sales Data etc.)
  4.10.1 Shanghai RAAS Profile
Table Shanghai RAAS Overview List
  4.10.2 Shanghai RAAS Products & Services
  4.10.3 Shanghai RAAS Business Operation Conditions
Table Business Operation of Shanghai RAAS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Bharat Serum (Company Profile, Sales Data etc.)
  4.11.1 Bharat Serum Profile
Table Bharat Serum Overview List
  4.11.2 Bharat Serum Products & Services
  4.11.3 Bharat Serum Business Operation Conditions
Table Business Operation of Bharat Serum (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 VINS (Company Profile, Sales Data etc.)
  4.12.1 VINS Profile
Table VINS Overview List
  4.12.2 VINS Products & Services
  4.12.3 VINS Business Operation Conditions
Table Business Operation of VINS (Sales Revenue, Cost, Gross Margin)

5 MARKET COMPETITION

5.1 Company Competition
Table Global Human Rabies Immunoglobulin (IM) Sales Revenue 2016-2020, by Company, in USD Million
Table Global Human Rabies Immunoglobulin (IM) Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Human Rabies Immunoglobulin (IM) Sales Revenue Share in 2020, by Company, in USD Million
Table Global Human Rabies Immunoglobulin (IM) Sales Volume 2016-2020, by Company, in Volume
Table Global Human Rabies Immunoglobulin (IM) Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Human Rabies Immunoglobulin (IM) Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Human Rabies Immunoglobulin (IM) Market Concentration, in 2020
Figure Europe Human Rabies Immunoglobulin (IM) Market Market Concentration, in 2020
Figure Asia-Pacific Human Rabies Immunoglobulin (IM) MMarket Concentration, in 2020
Figure South America Human Rabies Immunoglobulin (IM) Market Concentration, in 2020
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Market Concentration, in 2020

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Category II Exposure
Figure Human Rabies Immunoglobulin (IM) Demand in Category II Exposure, 2016-2020, in USD Million
Figure Human Rabies Immunoglobulin (IM) Demand in Category II Exposure, 2016-2020, in Volume
  6.1.2 Demand in Category III Exposure
Figure Human Rabies Immunoglobulin (IM) Demand in Category III Exposure, 2016-2020, in USD Million
Figure Human Rabies Immunoglobulin (IM) Demand in Category III Exposure, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Human Rabies Immunoglobulin (IM) Demand Forecast 2021-2026, by Application, in USD Million
Figure Human Rabies Immunoglobulin (IM) Market Growth 2021-2026, by Application, in USD Million
Figure Human Rabies Immunoglobulin (IM) Market Share in 2026, by Application, in USD Million
Table Human Rabies Immunoglobulin (IM) Demand Forecast 2021-2026, by Application, in Volume
Table Human Rabies Immunoglobulin (IM) Market Growth 2021-2026, by Application, in Volume
Table Human Rabies Immunoglobulin (IM) Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand

7 REGION OPERATION

7.1 Regional Production
Table Human Rabies Immunoglobulin (IM) Production 2016-2020, by Region, in USD Million
Table Human Rabies Immunoglobulin (IM) Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Human Rabies Immunoglobulin (IM) Market 2016-2020, by Region, in USD Million
Table Global Human Rabies Immunoglobulin (IM) Market Share 2016-2020, by Region, in USD Million
Table Global Human Rabies Immunoglobulin (IM) Market 2016-2020, by Region, in Volume
Table Global Human Rabies Immunoglobulin (IM) Market Share 2016-2020, by Region, in Volume
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
Figure North America Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in USD Million
Figure North America Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in Volume
    7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in USD Million
Table North America Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in Volume
  7.3.2 Europe
    7.3.2.1 Overview
Figure Europe Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in USD Million
Figure Europe Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in Volume
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in USD Million
Table Europe Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in Volume
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
Figure Asia-Pacific Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in Volume
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in Volume
  7.3.4 South America
    7.3.4.1 Overview
Figure South America Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in USD Million
Figure South America Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in Volume
    7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in USD Million
Table South America Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in Volume
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in Volume
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Human Rabies Immunoglobulin (IM) Market Forecast 2021-2026, by Region, in USD Million
Table Human Rabies Immunoglobulin (IM) Market Forecast 2021-2026, by Region, in Volume

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
Table Price Factors List
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview

9 RESEARCH CONCLUSION
LIST OF TABLES
1. Table Upstream Segment of Human Rabies Immunoglobulin (IM)
2. Table Application Segment of Human Rabies Immunoglobulin (IM)
3. Table Global Human Rabies Immunoglobulin (IM) Market 2016-2026, by Application, in USD Million
4. Table Major Company List of HRIG
5. Table Global Human Rabies Immunoglobulin (IM) Market 2016-2020, by Type, in USD Million
6. Table Global Human Rabies Immunoglobulin (IM) Market 2016-2020, by Type, in Volume
7. Table Global Human Rabies Immunoglobulin (IM) Market Forecast 2021-2026, by Type, in USD Million
8. Table Global Human Rabies Immunoglobulin (IM) Market Forecast 2021-2026, by Type, in Volume
9. Table CSL Behring Overview List
10. Table Business Operation of CSL Behring (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
11. Table GrifolsĀ  Overview List
12. Table Business Operation of GrifolsĀ  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table Sanofi Overview List
14. Table Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Sichuan Yuanda Shuyang Overview List
16. Table Business Operation of Sichuan Yuanda Shuyang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table CNBG Overview List
18. Table Business Operation of CNBG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Kamada Overview List
20. Table Business Operation of Kamada (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table CBPO Overview List
22. Table Business Operation of CBPO (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Shuanglin Bio Overview List
24. Table Business Operation of Shuanglin Bio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Weiguang Bio Overview List
26. Table Business Operation of Weiguang Bio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Shanghai RAAS Overview List
28. Table Business Operation of Shanghai RAAS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Bharat Serum Overview List
30. Table Business Operation of Bharat Serum (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table VINS Overview List
32. Table Business Operation of VINS (Sales Revenue, Cost, Gross Margin)
33. Table Global Human Rabies Immunoglobulin (IM) Sales Revenue 2016-2020, by Company, in USD Million
34. Table Global Human Rabies Immunoglobulin (IM) Sales Revenue Share 2016-2020, by Company, in USD Million
35. Table Global Human Rabies Immunoglobulin (IM) Sales Volume 2016-2020, by Company, in Volume
36. Table Global Human Rabies Immunoglobulin (IM) Sales Volume Share 2016-2020, by Company, in Volume
37. Table Regional Demand Comparison List
38. Table Major Application in Different Regions
39. Table Human Rabies Immunoglobulin (IM) Demand Forecast 2021-2026, by Application, in USD Million
40. Table Human Rabies Immunoglobulin (IM) Demand Forecast 2021-2026, by Application, in Volume
41. Table Human Rabies Immunoglobulin (IM) Market Growth 2021-2026, by Application, in Volume
42. Table Human Rabies Immunoglobulin (IM) Market Share in 2026, by Application, in Volume
43. Table Human Rabies Immunoglobulin (IM) Production 2016-2020, by Region, in USD Million
44. Table Human Rabies Immunoglobulin (IM) Production 2016-2020, by Region, in Volume
45. Table Global Human Rabies Immunoglobulin (IM) Market 2016-2020, by Region, in USD Million
46. Table Global Human Rabies Immunoglobulin (IM) Market Share 2016-2020, by Region, in USD Million
47. Table Global Human Rabies Immunoglobulin (IM) Market 2016-2020, by Region, in Volume
48. Table Global Human Rabies Immunoglobulin (IM) Market Share 2016-2020, by Region, in Volume
49. Table North America Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in USD Million
50. Table North America Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in Volume
51. Table Europe Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in USD Million
52. Table Europe Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in Volume
53. Table Asia-Pacific Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in USD Million
54. Table Asia-Pacific Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in Volume
55. Table South America Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in USD Million
56. Table South America Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in Volume
57. Table Middle East & Africa Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in USD Million
58. Table Middle East & Africa Human Rabies Immunoglobulin (IM) Market Size 2016-2020, by Country, in Volume
59. Table Human Rabies Immunoglobulin (IM) Market Forecast 2021-2026, by Region, in USD Million
60. Table Human Rabies Immunoglobulin (IM) Market Forecast 2021-2026, by Region, in Volume
61. Table Price Factors List
LIST OF FIGURES
1. Figure Human Rabies Immunoglobulin (IM) Industry Chain Structure
2. Figure Global Human Rabies Immunoglobulin (IM) Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Human Rabies Immunoglobulin (IM) Market Growth 2016-2020, by Type, in Volume
4. Figure Global Human Rabies Immunoglobulin (IM) Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Human Rabies Immunoglobulin (IM) Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Human Rabies Immunoglobulin (IM) Market Concentration, in 2020
7. Figure Europe Human Rabies Immunoglobulin (IM) Market Market Concentration, in 2020
8. Figure Asia-Pacific Human Rabies Immunoglobulin (IM) MMarket Concentration, in 2020
9. Figure South America Human Rabies Immunoglobulin (IM) Market Concentration, in 2020
10. Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Market Concentration, in 2020
11. Figure Human Rabies Immunoglobulin (IM) Demand in Category II Exposure, 2016-2020, in USD Million
12. Figure Human Rabies Immunoglobulin (IM) Demand in Category II Exposure, 2016-2020, in Volume
13. Figure Human Rabies Immunoglobulin (IM) Demand in Category III Exposure, 2016-2020, in USD Million
14. Figure Human Rabies Immunoglobulin (IM) Demand in Category III Exposure, 2016-2020, in Volume
15. Figure Human Rabies Immunoglobulin (IM) Market Growth 2021-2026, by Application, in USD Million
16. Figure Human Rabies Immunoglobulin (IM) Market Share in 2026, by Application, in USD Million
17. Figure North America Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in USD Million
18. Figure North America Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in Volume
19. Figure Europe Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in USD Million
20. Figure Europe Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in Volume
21. Figure Asia-Pacific Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in USD Million
22. Figure Asia-Pacific Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in Volume
23. Figure South America Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in USD Million
24. Figure South America Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in Volume
25. Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in USD Million
26. Figure Middle East & Africa Human Rabies Immunoglobulin (IM) Market Size and Growth 2016-2020, in Volume
27. Figure Marketing Channels Overview


More Publications